Management of Chronic Constipation: A Comprehensive Review
- PMID: 37952945
- PMCID: PMC11781917
- DOI: 10.2169/internalmedicine.2867-23
Management of Chronic Constipation: A Comprehensive Review
Abstract
Traditionally, the treatment of chronic constipation has focused on lifestyle modification, dietary guidance and therapy, and osmotic and stimulant laxatives. Recently, several drugs with new mechanisms of action have been introduced as treatments for chronic constipation. In Japan, polyethylene glycol and lactulose can now be administered under insurance coverage. The number of treatment options for constipation has increased dramatically. First, lifestyle modifications and dietary therapies must be implemented. If constipation does not improve sufficiently, specialized functional tests are performed to diagnose physiological subgroups. If functional tests are not available, patients are classified as having the "decreased frequency of defecation" type or the "difficult defecation" type based on the patient's symptoms, with treatment applied according to each type. Medical therapy includes osmotic laxatives, secretagogues, bile acid transporter inhibitors, probiotics, prokinetics, and Kampo medicines. The temporary use of stimulant laxatives, suppositories, enemas, and digital evacuation is also recommended. The usefulness of biofeedback is yet to be determined.
Keywords: elobixibat; linaclotide; lubiprostone; osmotic laxatives; stimulant laxatives.
Conflict of interest statement
Akihito Nagahara: Honoraria, Astellas Pharma, EA Pharma, Tsumura and Viatris.
Similar articles
-
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Evid Based Child Health. 2013. PMID: 23878124 Review.
-
Evidence-Based Clinical Guidelines for Chronic Constipation 2023.Digestion. 2025;106(1):62-89. doi: 10.1159/000540912. Epub 2024 Aug 19. Digestion. 2025. PMID: 39159626 Free PMC article.
-
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).World J Gastroenterol. 2012 Sep 28;18(36):4994-5013. doi: 10.3748/wjg.v18.i36.4994. World J Gastroenterol. 2012. PMID: 23049207 Free PMC article.
-
What is the Evidence for Over the Counter Laxatives to Treat Childhood Constipation?Curr Gastroenterol Rep. 2021 Oct 12;23(11):19. doi: 10.1007/s11894-021-00818-1. Curr Gastroenterol Rep. 2021. PMID: 34637057 Review.
-
Chronic constipation: current treatment options.Can J Gastroenterol. 2011 Oct;25 Suppl B(Suppl B):22B-28B. Can J Gastroenterol. 2011. PMID: 22114754 Free PMC article. Review.
Cited by
-
Causal relationship between gut microbiota and constipation: a bidirectional Mendelian randomization study.Front Microbiol. 2024 Jul 17;15:1438778. doi: 10.3389/fmicb.2024.1438778. eCollection 2024. Front Microbiol. 2024. PMID: 39086647 Free PMC article.
-
L-Arabinose Alleviates Functional Constipation in Mice by Regulating Gut Microbiota and Metabolites.Foods. 2025 Mar 6;14(5):900. doi: 10.3390/foods14050900. Foods. 2025. PMID: 40077603 Free PMC article.
References
-
- The Japanese Gastroenterological Association . In: Evidence-Based Clinical Practice Guidelines for Chronic Constipation. Nankodo, Tokyo, 2023. (in Japanese).
-
- Mearin F, Lacy BE, Chang L, et al. . Bowel disorders. Gastroenterology 150: 1393-1407, 2016. - PubMed
-
- Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology 158: 1262-1273.e3, 2020. - PubMed
-
- Schmidt FMQ, de Gouveia Santos VLC. Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs 41: 70-76; quiz E1-E2, 2014. - PubMed